Stanford restricts industry involvement in CME

September 16, 2008 Stanford restricts industry involvement in CME Barbara Boughton -------------------------------------------------------------------------------- Stanford University radiology officials are reevaluating their conflict of interest policies for continuing medical education programs in light of new School of Medicine rules that severely restrict funding from pharmaceutical and device companies. Under Stanford's new policy, effective Sept. 1, the medical school no longer accepts support from pharmaceutical or device companies for CME. All contributions for CME from medical industry must be funneled through a central office.

See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC